| |
| |
|
| Insider
Information: |
Kim Austin D. |
| Relationship: |
EVP,General Counsel, S... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
46,901 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$783,716 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
46,901 |
|
|
| Total
Value |
$783,716 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
13
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -89.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acadia Pharmaceuticals Inc |
ACAD |
EVP,General Counsel, S... |
2024-01-08 |
46,901 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2024-01-08 |
4 |
S |
$29.96 |
$17,676 |
D/D |
(590) |
46,901 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2024-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,634 |
47,491 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-10-06 |
4 |
S |
$21.96 |
$359,463 |
D/D |
(16,369) |
45,857 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-10-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,174 |
62,226 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-05-01 |
4 |
S |
$21.18 |
$19,422 |
D/D |
(917) |
25,513 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,005 |
26,430 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-04-06 |
4 |
S |
$18.16 |
$26,441 |
D/D |
(1,456) |
23,425 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,773 |
24,881 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-02-24 |
4 |
S |
$18.78 |
$15,080 |
D/D |
(803) |
20,108 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,214 |
20,911 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-01-09 |
4 |
S |
$17.13 |
$10,090 |
D/D |
(589) |
18,697 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2023-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,633 |
19,286 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2022-05-02 |
4 |
S |
$18.18 |
$16,255 |
D/D |
(894) |
16,742 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP,General Counsel, Secretary |
• – – |
2022-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,005 |
17,636 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2022-02-23 |
4 |
S |
$23.80 |
$18,612 |
D/D |
(782) |
14,631 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2022-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,213 |
15,413 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2022-01-06 |
4 |
S |
$23.05 |
$13,231 |
D/D |
(574) |
13,200 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2022-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,633 |
13,774 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-04-30 |
4 |
S |
$20.33 |
$21,428 |
D/D |
(1,054) |
11,371 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-04-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,005 |
12,425 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-02-04 |
4 |
S |
$50.61 |
$106,635 |
D/D |
(2,107) |
9,911 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,009 |
12,018 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-01-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,633 |
6,196 |
0 |
- |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2021-01-06 |
4 |
S |
$53.34 |
$36,165 |
D/D |
(678) |
5,518 |
0 |
% |
|
| ACAD |
Acadia Pharmaceuticals In... |
EVP & General Counsel |
• – – |
2020-10-27 |
4 |
AS |
$45.10 |
$394,636 |
D/D |
(8,750) |
3,851 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
